NCT04057768

Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles

Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Venus Concept · Industry
• Sex: All
• Age: 22 Years
• Healthy volunteers: Not accepted

Summary

The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.

Detailed description

Prospective, single centre, evaluator-blind, split face study of the efficacy of fractional radiofrequency (RF) for the treatment and reduction of acne scarring and facial wrinkles. The study will evaluate the progress of 15 subjects requesting treatment of scarring or facial wrinkles. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.

Conditions

• Acne Scars - Mixed Atrophic and Hypertrophic
• Wrinkle

Interventions

Type	Name	Description
DEVICE	Venus Viva	The Venus Viva™ fractional RF device has been shown in clinical studies to improve various skin conditions related to aging and alter collagen structures such as wrinkles, rhytids and scars.

Timeline

• Start date: 2019-08-19
• Primary completion: 2020-03-03
• Completion: 2020-03-03
• First posted: 2019-08-15
• Last updated: 2021-06-29
• Results posted: 2021-06-29

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study